Skip to content

Clinical trials

Phase 2 Myocardial Infarction trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 2 Country / region: Germany Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20061
20071
20082
20161
20191
20201
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer1
Biopure Corporation1
Boehringer Ingelheim1
Cardior Pharmaceuticals GmbH1
Charite University, Berlin, Germany1
Fibrex Medical Research & Development GmbH1
Johann Wolfgang Goethe University Hospital1
KAI Pharmaceuticals1
Novartis1
Quantum Genomics SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction11
Angina, Unstable3
Myocardial Ischemia3
Acute Coronary Syndrome1
Angina Pectoris1
COVID-191
Cardiovascular Diseases1
Coronary Artery Disease1
Coronary Disease1
Heart Diseases1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.